Liraglutide cardiovascular outcome trial aimed to assess long-term effects in type 2 diabetes
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
Abstract
The LEADER trial aimed to determine liraglutide's long-term cardiovascular effects in type 2 diabetes patients.